Previous 10 | Next 10 |
2023-03-23 19:28:02 ET Eargo, Inc. (EAR) Q4 2022 Earnings Call Transcript March 23, 2023 4:30 PM ET Company Participants Nick Laudico - Chief Retail Officer Christian Gormsen - President and Chief Executive Officer and Director Adam Laponis - Chief Financial Offi...
2023-03-23 16:12:28 ET Eargo press release ( NASDAQ: EAR ): Q4 Non-GAAP EPS of -$4.18. Revenue of $12.9M (+27.7% Y/Y). Gross systems shipped of 8,863, compared to 7,767 in the fourth quarter of 2021 Quarterly operating cash burn for the fourth quarter of 2022 was a...
Recent Highlights: Net revenues of $12.9 million in the fourth quarter of 2022, compared to $10.1 million in the fourth quarter of 2021 and $7.9 million in the third quarter of 2022 Gross systems shipped of 8,863, compared to 7,767 in the fourth quarter of 2021 GAAP operating lo...
SAN JOSE, Calif., March 17, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve hearing health, today announced it will release financial results for the fourth quarter 2022 after market close on March 23, 2023. On the same day, Eargo will host a c...
Summary Eargo, Inc. went public in October 2020, raising approximately $141 million in a U.S. IPO. The firm sells advanced hearing aid products in the United States. Eargo has had a rocky start to public company life, having to settle a DOJ investigation into false practices in subm...
Medical device firm Eargo ( NASDAQ: EAR ) said it had received a letter from the Nasdaq stating that it was in compliance and the minimum bid price deficiency had been cured. The letter from Nasdaq follows the company’s 1-for-20 reverse stock split, which came into eff...
SAN JOSE, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (the “Company” or “Eargo”), a medical device company on a mission to improve the quality of life of people with hearing loss, announced today that it received a letter from The Nasdaq Stock M...
SAN JOSE, Calif., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (“Eargo” or the “Company”) (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced that it has filed a Certificate of Amendment (th...
Hearing aid maker Eargo, Inc. ( NASDAQ: EAR ) announced Wednesday that its common stock would start trading on a split-adjusted basis when the market opens on Wednesday, Jan. 18, following a 1-for-20 reverse stock split. Accordingly, every 20 shares of Eargo’s ( EAR ) issue...
SAN JOSE, Calif., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (“Eargo” or the “Company”) (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced that its Board of Directors has approved a 1-for...
News, Short Squeeze, Breakout and More Instantly...
Swire Pacific Ltd. ADR (Class A) (SWRAY) is expected to report for Q4 2023 Troika Media Group Inc. (TRKAQ) is expected to report for quarter end 2023-12-31 American Environmental Partners Inc. (AEPT) is expected to report for quarter end 2023-12-31 Veolia Environnement S.A. ADR (VEOEY...
SAN JOSE, Calif., Jan. 31, 2024 (GLOBE NEWSWIRE) -- This quarter, Eargo, Inc. launches two new over-the-counter (OTC) hearing wellness devices, Eargo SE (launching today) and LINK by Eargo (launching in the first quarter of 2024). The new devices expand the brand’s portfolio of offerings w...
NEW YORK, NY / ACCESSWIRE / December 27, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Rain Oncology Inc. (NASDAQ:...